Rhode Island SB 573: AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name on list.)

Status: 05/09/2023 Committee recommended measure be held for further study (as of 2023-05-09)

State: Rhode Island · Session: 2023 · Bill: SB 573

Subjects: Business & Professions, Fees, Health & Safety, Labor, Prescription drugs

Sponsors: DiMario, DiPalma, Kallman, Lauria, Lawson, Miller, Murray, Valverde

View Rhode Island SB 573 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.